Rates of long-term treatment discontinuation were low among patients with ankylosing spondylitis receiving first-line anti-TNF therapy for at least 2 years.

Secukinumab is safe and effective over a 48-month period among patients with PsA, demonstrating sustained disease control and high drug retention rates.

HealthDay News — What time one eats impacts body mass index (BMI), according to a study published online Sept. 12 in the International Journal of Behavioral Nutrition and Physical Activity.

A healthy sleep pattern and a moderate level of physical activity is associated with a decreased risk of developing rheumatoid arthritis.

HealthDay News — For patients with ulcerative colitis, the HLA-DRB1*01:03 allele is associated with severe ulcerative colitis, according to a research letter published online Oct. 15 in the Journal of ...

While treatment with CZP significantly reduced inflammation among patients with active axSpA, this did not always translate into marked clinical improvements.

Rates of biochemical alcohol and drug screening are disproportionately higher among adolescent trauma patients who are from racial and ethnic minorities, have public or no insurance, or are female.

A nurse-supported cognitive behavioral therapy program can reduce insomnia symptoms and improve sleep outcomes in veterans.

Hyperandrogenemia was associated with obesity among girls with obesity during childhood, perimenarche, and late adolescence.

The researchers found that the number of exposures with seizures increased from 1,418 cases in 2009 to 2,749 cases in 2023, with an average of a 5 percent yearly increase. The number of exposures with ...

Women using levonorgestrel-releasing intrauterine systems (LNG-IUS) have an increased risk for breast cancer. HealthDay News — Women using levonorgestrel-releasing intrauterine systems (LNG-IUS) have ...

Patients not waitlisted for kidney transplant received breast or prostate cancer screening at lower-than-expected rates, including those with good life expectancy. Breast and prostate cancer ...